Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Daily News

Data Gap: Best Strategy Unknown for A-Fib Patients on Newer Anticoagulants Who Need PCI

L.A. McKeown

August 17, 2016

News Daily News

Ticagrelor Doesn’t Beat Aspirin for Secondary Prevention After Stroke-TIA: SOCRATES

Todd Neale

May 11, 2016

News Daily News

‘Smoker’s Paradox’ Eliminated With Double Dose of Clopidogrel: GRAVITAS Analysis

Michael O'Riordan

February 28, 2016

News Daily News

Upstream Bivalirudin Best in NSTE-ACS Patients With Planned Invasive Strategy

L.A. McKeown

September 21, 2015

News Daily News

Post-TAVR Aspirin Monotherapy No Less Effective, Possibly Safer Than DAPT

May 14, 2015

News Daily News

Dual Antiplatelet Therapy Tied to Better Outcomes in High Risk PAD Patients

Leah Lawrence

April 29, 2015

News Daily News

Patient-Level Pooled Analysis Supports Bivalirudin Use in Primary PCI

Yael L. Maxwell

January 12, 2015

News Daily News

Meta-Analysis: Worse Clinical Outcomes But Less Bleeding With Bivalirudin in PCI

Todd Neale

August 20, 2014

News Daily News

Prasugrel Noninferior to Ticagrelor in STEMI, but Both Require Hours to Achieve Effect

Yael L. Maxwell

May 13, 2013

News Daily News

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

October 31, 2011

News Daily News

Bivalirudin Decreases Bleeding Regardless of Heparin Anticoagulation Level

Yael L. Maxwell

October 13, 2011

News Daily News

Interruption of Antiplatelet Therapy Unnecessary for Tooth Extraction

July 27, 2011

News Daily News

Apixaban Increases Major Bleeding in High-Risk ACS Patients

Jason Kahn

July 25, 2011

News Daily News

Antithrombin Plus Preloading with Clopidogrel May Reduce Stent Thrombosis

L.A. McKeown

April 15, 2011

Advertisement

Data Gap: Best Strategy Unknown for A-Fib Patients on Newer Anticoagulants Who Need PCI

Ticagrelor Doesn’t Beat Aspirin for Secondary Prevention After Stroke-TIA: SOCRATES

‘Smoker’s Paradox’ Eliminated With Double Dose of Clopidogrel: GRAVITAS Analysis

Upstream Bivalirudin Best in NSTE-ACS Patients With Planned Invasive Strategy

Post-TAVR Aspirin Monotherapy No Less Effective, Possibly Safer Than DAPT

Dual Antiplatelet Therapy Tied to Better Outcomes in High Risk PAD Patients

Patient-Level Pooled Analysis Supports Bivalirudin Use in Primary PCI

Meta-Analysis: Worse Clinical Outcomes But Less Bleeding With Bivalirudin in PCI

Prasugrel Noninferior to Ticagrelor in STEMI, but Both Require Hours to Achieve Effect

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

Bivalirudin Decreases Bleeding Regardless of Heparin Anticoagulation Level

Interruption of Antiplatelet Therapy Unnecessary for Tooth Extraction

Apixaban Increases Major Bleeding in High-Risk ACS Patients

Antithrombin Plus Preloading with Clopidogrel May Reduce Stent Thrombosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content